Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave P Miller

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Chest|March 12, 2011
Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryLynette M Brown, Hubert Chen, Scott Halpern, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Chest|June 13, 2015
Five-Year outcomes of patients enrolled in the REVEAL RegistryHarrison W Farber, Dave P Miller, Abby D Poms, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyBradley E Chipps, Robert S Zeiger, Larry Borish, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|October 17, 2014
Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational studyRobert P Frantz, Robert J Schilz, Murali M Chakinala, et al.
Chest|October 20, 2009
Pulmonary arterial hypertension: baseline characteristics from the REVEAL RegistryDavid B Badesch, Gary E Raskob, C Greg Elliott, et al.
The European Respiratory Journal|April 4, 2015
Validation of two predictive models for survival in pulmonary arterial hypertensionOlivier Sitbon, Raymond L Benza, David B Badesch, et al.
Circulation|November 1, 2006
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategyDuane S Pinto, Ajay J Kirtane, Brahmajee K Nallamothu, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Chest|March 12, 2011
Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryLynette M Brown, Hubert Chen, Scott Halpern, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Chest|June 13, 2015
Five-Year outcomes of patients enrolled in the REVEAL RegistryHarrison W Farber, Dave P Miller, Abby D Poms, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyBradley E Chipps, Robert S Zeiger, Larry Borish, et al.
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|October 17, 2014
Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational studyRobert P Frantz, Robert J Schilz, Murali M Chakinala, et al.
Chest|October 20, 2009
Pulmonary arterial hypertension: baseline characteristics from the REVEAL RegistryDavid B Badesch, Gary E Raskob, C Greg Elliott, et al.
The European Respiratory Journal|April 4, 2015
Validation of two predictive models for survival in pulmonary arterial hypertensionOlivier Sitbon, Raymond L Benza, David B Badesch, et al.
Circulation|November 1, 2006
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategyDuane S Pinto, Ajay J Kirtane, Brahmajee K Nallamothu, et al.
Pageof 7